Abstract
The following new pharmaceuticals administered in the treatment of epilepsy are discussed: Sabril (vigabatrine), Lamictal (lamotrigine), Felbatol (felbamate), and Gabapentin (GBP). The paper presents the state-of-the-art (not quite sufficient yet) knowledge about these drugs. They are generally used as a supplementary medication in treatment conducted with another drug. The pharmaceuticals in question are characterized by specificity of action in certain types of epilepsy, and by a low toxicity.